FNBP1L

Across TCGA pan-cancer cohorts, FNBP1L mass-spec protein is linked to patient survival in 7 of 34 cancer types, making it a survival-associated FNBP1L data layer compared with 24 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher FNBP1L mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated FNBP1L expression acts as an unfavorable survival marker, although some lineages such as COAD and UCEC show a favorable association.

COAD, UCEC, and GBM are the cancer types where FNBP1L mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	All	1.000	0.877	.011	72	view →
UCEC	DFS	Median	II,III,IV	0.925	0.476	.002	48	view →
GBM	OS	Median	All	0.526	0.272	.006	6	view →
PDAC	OS	Median	All	0.285	0.547	.003	6	view →
CCRCC	DFS	Tertile	III,IV	0.780	0.435	.024	5	view →
LSCC	DFS	Median	III,IV	0.584	0.984	.031	4	view →
LUAD	OS	Quartile	III,IV	0.993	0.618	.040	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

FNBP1L–COAD (DFS)

Open the COAD breakdown →